{"id":76965,"date":"2026-11-09T21:19:30","date_gmt":"2026-11-09T21:19:30","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76965"},"modified":"2026-11-09T21:19:30","modified_gmt":"2026-11-09T21:19:30","slug":"american-analyst-updates-nov-9th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/","title":{"rendered":"American Analyst Updates: Nov 9th, 2026"},"content":{"rendered":"<h2><a href=\"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76965&amp;preview=true\">Analyst Ratings (USA)<\/a><\/h2>\n<p>American sentiment on November 9th remains cautiously optimistic but increasingly selective, with positive recommendations concentrated in artificial intelligence, semiconductors, industrials, and select financial and healthcare companies. Upgrades and higher price targets reflect confidence in long-term earnings growth and improving business fundamentals, while significant target reductions across technology, software, consumer discretionary, and energy-related stocks indicate growing concerns about elevated valuations and profitability. Multiple downgrades in online gaming and other consumer-facing businesses highlight a more defensive approach to risk.<\/p>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<h3>Updates (450)<\/h3>\n<p><strong>10x Genomics (TXG)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $70.00 from $110.00.<\/p>\n<p><strong>Acadia Realty Trust (AKR)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $24.00 from $26.00.<\/p>\n<p><strong>Advance Auto Parts (AAP)<\/strong> \u2014 TD Cowen maintains its Hold rating and raises its price target to $47.00 from $45.00.<\/p>\n<p><strong>Advanced Micro Devices (AMD)<\/strong> \u2014 Oppenheimer upgrades the stock from Market Perform to Outperform with a price target of $600.00.<\/p>\n<p><strong>AdvanSix (ASIX)<\/strong> \u2014 Truist Financial maintains its Hold rating and lowers its price target to $16.00 from $18.00.<\/p>\n<p><strong>AerSale (ASLE)<\/strong> \u2014 B. Riley Financial maintains its Neutral rating and lowers its price target to $5.50 from $6.00.<\/p>\n<p><strong>Affirm (AFRM)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $84.00 from $97.00.<\/p>\n<p><strong>Affirm (AFRM)<\/strong> \u2014 Sanford C. Bernstein reiterates its Outperform rating.<\/p>\n<p><strong>Aflac (AFL)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and raises its price target to $143.00 from $138.00.<\/p>\n<p><strong>Agenus (AGEN)<\/strong> \u2014 B. Riley Financial reiterates its Buy rating with a price target of $16.00 from $14.00.<\/p>\n<p><strong>Air Products and Chemicals (APD)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $335.00 from $312.00.<\/p>\n<p><strong>Airbnb (ABNB)<\/strong> \u2014 Rothschild &amp; Co Redburn upgrades the stock from Sell to Neutral with a price target of $190.00 from $135.00.<\/p>\n<p><strong>Airbnb (ABNB)<\/strong> \u2014 Sanford C. Bernstein reiterates its Outperform rating.<\/p>\n<p><strong>Akamai Technologies (AKAM)<\/strong> \u2014 Robert W. Baird maintains its Neutral rating and lowers its price target to $92.00 from $140.00.<\/p>\n<p><strong>Albemarle (ALB)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $140.00 from $125.00.<\/p>\n<p><strong>Albemarle (ALB)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and lowers its price target to $105.00 from $161.00.<\/p>\n<p><strong>Albemarle (ALB)<\/strong> \u2014 Scotiabank maintains its Sector Outperform rating and lowers its price target to $165.00 from $190.00.<\/p>\n<p><strong>Algonquin Power &amp; Utilities (AQN)<\/strong> \u2014 BMO Capital Markets maintains its Market Perform rating and lowers its price target to $6.00 from $6.50.<\/p>\n<p><strong>Algonquin Power &amp; Utilities (AQN)<\/strong> \u2014 National Bank Financial maintains its Outperform rating and lowers its price target to $6.50 from $7.00.<\/p>\n<p><strong>Algonquin Power &amp; Utilities (AQN)<\/strong> \u2014 Raymond James Financial reiterates its Outperform rating with a price target of $7.00 from $7.25.<\/p>\n<p><strong>Alibaba Group (BABA)<\/strong> \u2014 Wells Fargo &amp; Company sets a price target of $190.00.<\/p>\n<p><strong>Allstate (ALL)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and lowers its price target to $294.00 from $300.00.<\/p>\n<p><strong>Amaero (AMRO)<\/strong> \u2014 Robert W. Baird initiates coverage with a Outperform rating with a price target of $9.00.<\/p>\n<p><strong>Ameren (AEE)<\/strong> \u2014 Mizuho maintains its Outperform rating and raises its price target to $123.00 from $113.00.<\/p>\n<p><strong>American Financial Group (AFG)<\/strong> \u2014 Keefe, Bruyette &amp; Woods maintains its Market Perform rating and raises its price target to $150.00 from $147.00.<\/p>\n<p><strong>American Financial Group (AFG)<\/strong> \u2014 Oppenheimer sets a price target of $150.00.<\/p>\n<p><strong>American International Group (AIG)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and raises its price target to $85.00 from $84.00.<\/p>\n<p><strong>Amkor Technology (AMKR)<\/strong> \u2014 B. Riley Financial maintains its Neutral rating and lowers its price target to $38.00 from $41.00.<\/p>\n<p><strong>AMN Healthcare Services (AMN)<\/strong> \u2014 Truist Financial maintains its Buy rating and raises its price target to $45.00 from $40.00.<\/p>\n<p><strong>Amrize (AMRZ)<\/strong> \u2014 Berenberg Bank downgrades the stock from Buy to Hold with a price target of $46.00 from $48.00.<\/p>\n<p><strong>APA (APA)<\/strong> \u2014 Truist Financial maintains its Hold rating and raises its price target to $50.00 from $45.00.<\/p>\n<p><strong>Apple Hospitality REIT (APLE)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintains its Neutral rating and raises its price target to $18.00 from $17.00.<\/p>\n<p><strong>Applied Digital (APLD)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and lowers its price target to $25.00 from $41.00.<\/p>\n<p><strong>Applied Materials (AMAT)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $475.00 from $700.00.<\/p>\n<p><strong>Ares Commercial Real Estate (ACRE)<\/strong> \u2014 Keefe, Bruyette &amp; Woods reiterates its Outperform rating.<\/p>\n<p><strong>Ares Commercial Real Estate (ACRE)<\/strong> \u2014 Truist Financial sets a price target of $4.25.<\/p>\n<p><strong>Ares Commercial Real Estate (ACRE)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Underweight rating and lowers its price target to $3.50 from $5.00.<\/p>\n<p><strong>Arhaus (ARHS)<\/strong> \u2014 TD Cowen maintains its Buy rating and raises its price target to $16.00 from $11.00.<\/p>\n<p><strong>Arrow Financial (AROW)<\/strong> \u2014 Piper Sandler reiterates its Overweight rating with a price target of $45.00 from $46.00.<\/p>\n<p><strong>Asbury Automotive Group (ABG)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $200.00 from $184.00.<\/p>\n<p><strong>Ashland (ASH)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Equal Weight rating and raises its price target to $80.00 from $75.00.<\/p>\n<p><strong>Assurant (AIZ)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and raises its price target to $330.00 from $300.00.<\/p>\n<p><strong>Assurant (AIZ)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and raises its price target to $356.00 from $329.00.<\/p>\n<p><strong>AST SpaceMobile (ASTS)<\/strong> \u2014 Cantor Fitzgerald reiterates its Overweight rating.<\/p>\n<p><strong>Astec Industries (ASTE)<\/strong> \u2014 Freedom Broker maintains its Buy rating and lowers its price target to $52.00 from $60.00.<\/p>\n<p><strong>Atlas Energy Solutions (AESI)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and lowers its price target to $21.00 from $25.00.<\/p>\n<p><strong>Atlassian (TEAM)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $210.00 from $222.00.<\/p>\n<p><strong>Atlassian (TEAM)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $220.00 from $245.00.<\/p>\n<p><strong>Atmus Filtration Technologies (ATMU)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintains its Overweight rating and raises its price target to $60.00 from $54.00.<\/p>\n<p><strong>Autodesk (ADSK)<\/strong> \u2014 Jefferies Financial Group reiterates its Buy rating with a price target of $325.00.<\/p>\n<p><strong>AutoNation (AN)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $182.00 from $175.00.<\/p>\n<p><strong>AvePoint (AVPT)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $17.00 from $14.00.<\/p>\n<p><strong>Avient (AVNT)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Overweight rating and raises its price target to $55.00 from $48.00.<\/p>\n<p><strong>Axon Enterprise (AXON)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $507.00 from $688.00.<\/p>\n<p><strong>Banc of California (BANC)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Overweight rating and lowers its price target to $21.00 from $22.00.<\/p>\n<p><strong>Bancorp (TBBK)<\/strong> \u2014 Piper Sandler reiterates its Overweight rating with a price target of $62.00 from $75.00.<\/p>\n<p><strong>Bank of Hawaii (BOH)<\/strong> \u2014 Keefe, Bruyette &amp; Woods upgrades the stock from Market Perform to Outperform with a price target of $85.00.<\/p>\n<p><strong>BankUnited (BKU)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Equal Weight rating and lowers its price target to $46.00 from $47.00.<\/p>\n<p><strong>Baxter International (BAX)<\/strong> \u2014 Barclays maintains its Underweight rating and raises its price target to $23.00 from $20.00.<\/p>\n<p><strong>Beauty Health (SKIN)<\/strong> \u2014 Raymond James Financial sets a price target of $14.00.<\/p>\n<p><strong>Beauty Health (SKIN)<\/strong> \u2014 TD Cowen reiterates its Hold rating with a price target of $14.00 from $0.90.<\/p>\n<p><strong>BETA Technologies (BETA)<\/strong> \u2014 Jefferies Financial Group downgrades the stock from Buy to Hold with a price target of $27.00 from $29.00.<\/p>\n<p><strong>BILL (BILL)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $60.00 from $55.00.<\/p>\n<p><strong>BILL (BILL)<\/strong> \u2014 TD Cowen maintains its Buy rating and raises its price target to $66.00 from $59.00.<\/p>\n<p><strong>BioAge Labs (BIOA)<\/strong> \u2014 BTIG Research reiterates its Buy rating.<\/p>\n<p><strong>Biodesix (BDSX)<\/strong> \u2014 HC Wainwright maintains its Buy rating and lowers its price target to $34.00 from $38.00.<\/p>\n<p><strong>Biogen (BIIB)<\/strong> \u2014 Piper Sandler reiterates its Overweight rating with a price target of $305.00 from $245.00.<\/p>\n<p><strong>BioNTech (BNTX)<\/strong> \u2014 HC Wainwright maintains its Buy rating and lowers its price target to $110.00 from $130.00.<\/p>\n<p><strong>BKV (BKV)<\/strong> \u2014 Truist Financial maintains its Buy rating and lowers its price target to $31.00 from $34.00.<\/p>\n<p><strong>Black Rock Coffee Bar (BRCB)<\/strong> \u2014 Stifel Nicolaus initiates coverage with a Hold rating with a price target of $12.00.<\/p>\n<p><strong>BlackLine (BL)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $40.00 from $45.00.<\/p>\n<p><strong>BlackLine (BL)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and lowers its price target to $28.00 from $30.00.<\/p>\n<p><strong>Blackrock Tcp Capital (TCPC)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Equal Weight rating and raises its price target to $4.50 from $4.00.<\/p>\n<p><strong>Block (XYZ)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and raises its price target to $102.00 from $95.00.<\/p>\n<p><strong>Bloom Energy (BE)<\/strong> \u2014 Royal Bank Of Canada reiterates its Outperform rating with a price target of $335.00.<\/p>\n<p><strong>Boot Barn (BOOT)<\/strong> \u2014 BTIG Research reiterates its Buy rating with a price target of $195.00.<\/p>\n<p><strong>BOX (BOX)<\/strong> \u2014 DA Davidson maintains its Buy rating and raises its price target to $60.00 from $50.00.<\/p>\n<p><strong>Brookdale Senior Living (BKD)<\/strong> \u2014 Stephens maintains its Overweight rating and lowers its price target to $12.00 from $17.00.<\/p>\n<p><strong>Brookfield Asset Management (BAM)<\/strong> \u2014 National Bank Financial maintains its Outperform rating and raises its price target to $72.00 from $70.00.<\/p>\n<p><strong>Brookfield Asset Management (BAM)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and raises its price target to $52.00 from $49.00.<\/p>\n<p><strong>Brookfield Asset Management (BAM)<\/strong> \u2014 Scotia maintains its Sector Outperform rating and raises its price target to $60.50 from $59.00.<\/p>\n<p><strong>Brookfield Asset Management (BAM)<\/strong> \u2014 Scotiabank maintains its Sector Outperform rating and sets a price target of $60.50 from $59.00.<\/p>\n<p><strong>Cabaletta Bio (CABA)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $8.00.<\/p>\n<p><strong>Camden Property Trust (CPT)<\/strong> \u2014 Cantor Fitzgerald maintains its Neutral rating and lowers its price target to $101.00 from $111.00.<\/p>\n<p><strong>Camping World (CWH)<\/strong> \u2014 Wells Fargo &amp; Company initiates coverage with a Overweight rating with a price target of $6.00.<\/p>\n<p><strong>Camtek (CAMT)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $138.00 from $166.00.<\/p>\n<p><strong>Cardinal Health (CAH)<\/strong> \u2014 TD Cowen maintains its Buy rating and raises its price target to $304.00 from $280.00.<\/p>\n<p><strong>CarGurus (CARG)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $41.00 from $38.00.<\/p>\n<p><strong>CarGurus (CARG)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $41.00 from $39.00.<\/p>\n<p><strong>Carlyle Secured Lending (CGBD)<\/strong> \u2014 Raymond James Financial reiterates its Outperform rating with a price target of $12.00.<\/p>\n<p><strong>Castle Biosciences (CSTL)<\/strong> \u2014 Robert W. Baird maintains its Outperform rating and raises its price target to $41.00 from $39.00.<\/p>\n<p><strong>CAVA Group (CAVA)<\/strong> \u2014 Mizuho maintains its Neutral rating and lowers its price target to $54.00 from $56.00.<\/p>\n<p><strong>Celanese (CE)<\/strong> \u2014 BMO Capital Markets reiterates its Market Perform rating with a price target of $58.00.<\/p>\n<p><strong>Celanese (CE)<\/strong> \u2014 KeyCorp maintains its Overweight rating and raises its price target to $59.00 from $57.00.<\/p>\n<p><strong>Celcuity (CELC)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating with a price target of $70.50.<\/p>\n<p><strong>Celcuity (CELC)<\/strong> \u2014 HC Wainwright maintains its Buy rating and lowers its price target to $150.00 from $155.00.<\/p>\n<p><strong>Celestica (CLS)<\/strong> \u2014 Sanford C. Bernstein maintains its Outperform rating and lowers its price target to $340.00 from $495.00.<\/p>\n<p><strong>Celldex Therapeutics (CLDX)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and raises its price target to $68.00 from $60.00.<\/p>\n<p><strong>Celldex Therapeutics (CLDX)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and raises its price target to $61.00 from $57.00.<\/p>\n<p><strong>Century Aluminum (CENX)<\/strong> \u2014 Barclays maintains its Equal Weight rating and lowers its price target to $39.00 from $40.00.<\/p>\n<p><strong>Cerebras Systems (CBRS)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $178.00 from $279.00.<\/p>\n<p><strong>Cerebras Systems (CBRS)<\/strong> \u2014 Wedbush maintains its Outperform rating and lowers its price target to $190.00 from $290.00.<\/p>\n<p><strong>CF Industries (CF)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $125.00 from $115.00.<\/p>\n<p><strong>CG Oncology (CGON)<\/strong> \u2014 Guggenheim maintains its Buy rating and lowers its price target to $89.00 from $90.00.<\/p>\n<p><strong>Charter Communications (CHTR)<\/strong> \u2014 TD Cowen maintains its Buy rating and lowers its price target to $345.00 from $372.00.<\/p>\n<p><strong>Charter Communications (CHTR)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Underweight rating and raises its price target to $103.00 from $101.00.<\/p>\n<p><strong>Charter Communications (CHTR)<\/strong> \u2014 Williams Trading sets a price target of $345.00.<\/p>\n<p><strong>Chemours (CC)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintains its Neutral rating and lowers its price target to $14.00 from $15.00.<\/p>\n<p><strong>Chesapeake Utilities (CPK)<\/strong> \u2014 Mizuho sets a price target of $155.00.<\/p>\n<p><strong>Chesapeake Utilities (CPK)<\/strong> \u2014 UBS Group reiterates its Outperform rating with a price target of $141.25.<\/p>\n<p><strong>Chimera Investment (CIM)<\/strong> \u2014 Keefe, Bruyette &amp; Woods maintains its Market Perform rating and lowers its price target to $11.50 from $13.00.<\/p>\n<p><strong>Choice Hotels International (CHH)<\/strong> \u2014 Robert W. Baird maintains its Outperform rating and raises its price target to $131.00 from $128.00.<\/p>\n<p><strong>Cigna Group (CI)<\/strong> \u2014 Barclays maintains its Equal Weight rating and raises its price target to $320.00 from $310.00.<\/p>\n<p><strong>Cipher Mining (CIFR)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $27.50.<\/p>\n<p><strong>Citizens (CIZN)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating with a price target of $10.00.<\/p>\n<p><strong>Citizens (CIZN)<\/strong> \u2014 Wells Fargo &amp; Company sets a price target of $5.50.<\/p>\n<p><strong>Coeur Mining (CDE)<\/strong> \u2014 Needham &amp; Company LLC sets a price target of $23.50.<\/p>\n<p><strong>Coeur Mining (CDE)<\/strong> \u2014 New Street Research sets a price target of $23.50.<\/p>\n<p><strong>Coeur Mining (CDE)<\/strong> \u2014 Scotiabank maintains its Sector Outperform rating and lowers its price target to $23.50 from $26.50.<\/p>\n<p><strong>Cogent Biosciences (COGT)<\/strong> \u2014 HC Wainwright maintains its Buy rating and raises its price target to $56.00 from $55.00.<\/p>\n<p><strong>Cogent Communications (CCOI)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $5.20 from $11.50.<\/p>\n<p><strong>Cognex (CGNX)<\/strong> \u2014 DA Davidson maintains its Neutral rating and lowers its price target to $55.00 from $65.00.<\/p>\n<p><strong>Cohu (COHU)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $60.00 from $75.00.<\/p>\n<p><strong>Commerce Bancshares (CBSH)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Equal Weight rating and lowers its price target to $60.00 from $61.00.<\/p>\n<p><strong>Compass Pathways (CMPS)<\/strong> \u2014 HC Wainwright reiterates its Buy rating.<\/p>\n<p><strong>Compass Pathways (CMPS)<\/strong> \u2014 Jefferies Financial Group reiterates its Buy rating.<\/p>\n<p><strong>Concentra Group Holdings Parent (CON)<\/strong> \u2014 Mizuho sets a price target of $47.00.<\/p>\n<p><strong>Concentra Group Holdings Parent (CON)<\/strong> \u2014 Stephens maintains its Overweight rating and raises its price target to $51.00 from $45.00.<\/p>\n<p><strong>ConocoPhillips (COP)<\/strong> \u2014 Truist Financial maintains its Hold rating and raises its price target to $142.00 from $136.00.<\/p>\n<p><strong>Construction Partners (ROAD)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $100.00 from $135.00.<\/p>\n<p><strong>Cooper-Standard (CPS)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $19.00 from $25.00.<\/p>\n<p><strong>Cooper-Standard (CPS)<\/strong> \u2014 Freedom Broker maintains its Buy rating and lowers its price target to $27.00 from $45.00.<\/p>\n<p><strong>Core Scientific (CORZ)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $27.00 from $31.00.<\/p>\n<p><strong>CoreWeave (CRWV)<\/strong> \u2014 Rosenblatt Securities maintains its Buy rating and lowers its price target to $160.00 from $250.00.<\/p>\n<p><strong>CoreWeave (CRWV)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Overweight rating and lowers its price target to $115.00 from $160.00.<\/p>\n<p><strong>Corning (GLW)<\/strong> \u2014 Sanford C. Bernstein maintains its Market Perform rating and lowers its price target to $120.00 from $140.00.<\/p>\n<p><strong>Corpay (CPAY)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and raises its price target to $550.00 from $480.00.<\/p>\n<p><strong>Coty (COTY)<\/strong> \u2014 Barclays maintains its Underweight rating and raises its price target to $3.00 from $2.00.<\/p>\n<p><strong>Cummins (CMI)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $600.00 from $675.00.<\/p>\n<p><strong>Curtiss-Wright (CW)<\/strong> \u2014 Stifel Nicolaus maintains its Hold rating and lowers its price target to $472.00 from $518.00.<\/p>\n<p><strong>CVB Financial (CVBF)<\/strong> \u2014 DA Davidson maintains its Neutral rating and raises its price target to $26.00 from $25.00.<\/p>\n<p><strong>D-Wave Quantum (QBTS)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $22.00 from $27.00.<\/p>\n<p><strong>Delcath Systems (DCTH)<\/strong> \u2014 BTIG Research maintains its Buy rating and raises its price target to $25.00 from $21.00.<\/p>\n<p><strong>Delek US (DK)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $70.00 from $62.00.<\/p>\n<p><strong>Devon Energy (DVN)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintains its Overweight rating and raises its price target to $68.00 from $65.00.<\/p>\n<p><strong>Devon Energy (DVN)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $64.00 from $65.00.<\/p>\n<p><strong>Devon Energy (DVN)<\/strong> \u2014 Susquehanna maintains its Positive rating and lowers its price target to $60.00 from $63.00.<\/p>\n<p><strong>Devon Energy (DVN)<\/strong> \u2014 Truist Financial maintains its Buy rating and raises its price target to $62.00 from $61.00.<\/p>\n<p><strong>Disc Medicine (IRON)<\/strong> \u2014 Guggenheim initiates coverage with a Buy rating with a price target of $132.00.<\/p>\n<p><strong>DNOW (DNOW)<\/strong> \u2014 Freedom Broker upgrades the stock from Hold to Buy with a price target of $18.00.<\/p>\n<p><strong>Docebo (DCBO)<\/strong> \u2014 ATB Cormark Capital Markets maintains its Outperform rating and raises its price target to $49.00 from $44.00.<\/p>\n<p><strong>Docebo (DCBO)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and raises its price target to $41.50 from $36.00.<\/p>\n<p><strong>Docebo (DCBO)<\/strong> \u2014 National Bank Financial maintains its Sector Perform rating and raises its price target to $32.00 from $31.00.<\/p>\n<p><strong>Docebo (DCBO)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and raises its price target to $36.00 from $28.00.<\/p>\n<p><strong>DraftKings (DKNG)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $27.00 from $34.00.<\/p>\n<p><strong>DraftKings (DKNG)<\/strong> \u2014 BTIG Research maintains its Buy rating and lowers its price target to $23.00 from $26.00.<\/p>\n<p><strong>DraftKings (DKNG)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and lowers its price target to $30.00 from $40.00.<\/p>\n<p><strong>DraftKings (DKNG)<\/strong> \u2014 Jefferies Financial Group reiterates its Buy rating with a price target of $28.00.<\/p>\n<p><strong>DraftKings (DKNG)<\/strong> \u2014 JPMorgan Chase &amp; Co. downgrades the stock from Overweight to Neutral with a price target of $21.00 from $30.00.<\/p>\n<p><strong>DraftKings (DKNG)<\/strong> \u2014 Mizuho maintains its Outperform rating and lowers its price target to $35.00 from $45.00.<\/p>\n<p><strong>DraftKings (DKNG)<\/strong> \u2014 Needham &amp; Company LLC maintains its Buy rating and lowers its price target to $25.00 from $30.00.<\/p>\n<p><strong>DraftKings (DKNG)<\/strong> \u2014 Sanford C. Bernstein maintains its Outperform rating and lowers its price target to $22.00 from $27.00.<\/p>\n<p><strong>DraftKings (DKNG)<\/strong> \u2014 Stifel Nicolaus downgrades the stock from Buy to Hold with a price target of $21.00 from $32.00.<\/p>\n<p><strong>DraftKings (DKNG)<\/strong> \u2014 Susquehanna reiterates its Positive rating with a price target of $23.00.<\/p>\n<p><strong>DraftKings (DKNG)<\/strong> \u2014 TD Cowen maintains its Buy rating and lowers its price target to $25.00 from $35.00.<\/p>\n<p><strong>DraftKings (DKNG)<\/strong> \u2014 Truist Financial maintains its Buy rating and lowers its price target to $22.00 from $26.00.<\/p>\n<p><strong>DraftKings (DKNG)<\/strong> \u2014 UBS downgrades the stock from Buy to Neutral with a price target of $22.<\/p>\n<p><strong>DraftKings (DKNG)<\/strong> \u2014 UBS Group downgrades the stock from Buy to Neutral with a price target of $22.00 from $48.00.<\/p>\n<p><strong>Dutch Bros (BROS)<\/strong> \u2014 Stifel Nicolaus initiates coverage with a Buy rating with a price target of $48.00.<\/p>\n<p><strong>DXP Enterprises (DXPE)<\/strong> \u2014 Freedom Broker upgrades the stock from Hold to Buy with a price target of $175.00 from $180.00.<\/p>\n<p><strong>East West Bancorp (EWBC)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Overweight rating and raises its price target to $155.00 from $150.00.<\/p>\n<p><strong>Eaton (ETN)<\/strong> \u2014 Raymond James Financial reiterates its Outperform rating with a price target of $485.00.<\/p>\n<p><strong>Elanco Animal Health (ELAN)<\/strong> \u2014 KeyCorp reiterates its Overweight rating.<\/p>\n<p><strong>Envoy Medical (COCH)<\/strong> \u2014 HC Wainwright reiterates its Buy rating with a price target of $18.00.<\/p>\n<p><strong>Eos Energy Enterprises (EOSE)<\/strong> \u2014 B. Riley Financial maintains its Neutral rating and lowers its price target to $2.00 from $5.00.<\/p>\n<p><strong>Eos Energy Enterprises (EOSE)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and lowers its price target to $4.00 from $9.00.<\/p>\n<p><strong>Essent Group (ESNT)<\/strong> \u2014 Barclays maintains its Equal Weight rating and lowers its price target to $65.00 from $66.00.<\/p>\n<p><strong>Essex Property Trust (ESS)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $305.00 from $316.00.<\/p>\n<p><strong>Eupraxia Pharmaceuticals (EPRX)<\/strong> \u2014 Royal Bank Of Canada initiates coverage with a Outperform rating with a price target of $14.00.<\/p>\n<p><strong>EverCommerce (EVCM)<\/strong> \u2014 Barclays maintains its Underweight rating and lowers its price target to $8.50 from $10.00.<\/p>\n<p><strong>Evergy (EVRG)<\/strong> \u2014 Mizuho sets a price target of $91.00.<\/p>\n<p><strong>Exp World (AGNT)<\/strong> \u2014 Citizens Jmp maintains its Market Outperform rating and lowers its price target to $5.50 from $6.00.<\/p>\n<p><strong>Fastly (FSLY)<\/strong> \u2014 Freedom Broker maintains its Buy rating and lowers its price target to $35.00 from $37.00.<\/p>\n<p><strong>Federal Realty Investment Trust (FRT)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $121.00 from $130.00.<\/p>\n<p><strong>Fervo Energy (FRVO)<\/strong> \u2014 Sanford C. Bernstein reiterates its Outperform rating with a price target of $47.00.<\/p>\n<p><strong>Fidelity National Financial (FNF)<\/strong> \u2014 Barclays maintains its Equal Weight rating and raises its price target to $49.00 from $47.00.<\/p>\n<p><strong>Fidelity National Information Services (FIS)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $34.00 from $45.00.<\/p>\n<p><strong>Fidus Investment (FDUS)<\/strong> \u2014 Keefe, Bruyette &amp; Woods maintains its Market Perform rating and raises its price target to $20.00 from $19.50.<\/p>\n<p><strong>Figure Technology Solutions (FIGR)<\/strong> \u2014 Keefe, Bruyette &amp; Woods maintains its Outperform rating and lowers its price target to $37.00 from $45.00.<\/p>\n<p><strong>First BanCorp. (FBP)<\/strong> \u2014 Piper Sandler reiterates its Neutral rating with a price target of $28.00 from $30.00.<\/p>\n<p><strong>First BanCorp. (FBP)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Overweight rating and lowers its price target to $30.00 from $32.00.<\/p>\n<p><strong>First Horizon (FHN)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Equal Weight rating and raises its price target to $26.00 from $25.00.<\/p>\n<p><strong>First Interstate BancSystem (FIBK)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Underweight rating and raises its price target to $36.00 from $34.00.<\/p>\n<p><strong>First Solar (FSLR)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and lowers its price target to $222.00 from $251.00.<\/p>\n<p><strong>Fiserv (FISV)<\/strong> \u2014 Cantor Fitzgerald maintains its Neutral rating and raises its price target to $65.00 from $48.00.<\/p>\n<p><strong>Fluor (FLR)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $66.00 from $68.00.<\/p>\n<p><strong>Fluor (FLR)<\/strong> \u2014 Robert W. Baird maintains its Neutral rating and lowers its price target to $56.00 from $64.00.<\/p>\n<p><strong>Fluor (FLR)<\/strong> \u2014 Truist Financial reiterates its Buy rating with a price target of $62.00 from $71.00.<\/p>\n<p><strong>FormFactor (FORM)<\/strong> \u2014 B. Riley Financial maintains its Overweight rating and lowers its price target to $22.00 from $21.00.<\/p>\n<p><strong>Fox Corporation (FOXA)<\/strong> \u2014 Seaport Research Partners upgrades the stock from Neutral to Buy with a price target of $76.<\/p>\n<p><strong>Franklin Resources (BEN)<\/strong> \u2014 Barclays maintains its Equal Weight rating and raises its price target to $36.00 from $34.00.<\/p>\n<p><strong>Franklin Resources (BEN)<\/strong> \u2014 Keefe, Bruyette &amp; Woods reiterates its Market Perform rating with a price target of $38.00 from $37.00.<\/p>\n<p><strong>Franklin Resources (BEN)<\/strong> \u2014 TD Cowen maintains its Buy rating and raises its price target to $44.00 from $38.00.<\/p>\n<p><strong>Fresenius Medical Care AG &amp; Co. KGaA (FMS)<\/strong> \u2014 Barclays downgrades the stock from Equal Weight to Underweight.<\/p>\n<p><strong>Frontdoor (FTDR)<\/strong> \u2014 The Goldman Sachs Group maintains its Neutral rating and raises its price target to $93.00 from $81.00.<\/p>\n<p><strong>FrontView REIT (FVR)<\/strong> \u2014 Freedom Broker maintains its Buy rating and lowers its price target to $21.00 from $22.00.<\/p>\n<p><strong>Galaxy Digital (GLXY)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $27.00 from $43.00.<\/p>\n<p><strong>Generac (GNRC)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and lowers its price target to $266.00 from $279.00.<\/p>\n<p><strong>Genpact (G)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $44.00 from $36.00.<\/p>\n<p><strong>Gildan Activewear (GIL)<\/strong> \u2014 BMO Capital Markets reiterates its Outperform rating with a price target of $40.00.<\/p>\n<p><strong>Global Payments (GPN)<\/strong> \u2014 Barclays maintains its Equal Weight rating and raises its price target to $97.00 from $89.00.<\/p>\n<p><strong>Global Payments (GPN)<\/strong> \u2014 Cantor Fitzgerald maintains its Neutral rating and raises its price target to $103.00 from $91.00.<\/p>\n<p><strong>Globus Medical (GMED)<\/strong> \u2014 Truist Financial maintains its Buy rating and lowers its price target to $90.00 from $100.00.<\/p>\n<p><strong>Goodyear Tire &amp; Rubber (GT)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $5.00 from $8.00.<\/p>\n<p><strong>Graham (GHC)<\/strong> \u2014 William Blair initiates coverage with a Outperform rating with a price target of $1,214.83.<\/p>\n<p><strong>Graham (GHM)<\/strong> \u2014 William Blair initiates coverage with a Outperform rating.<\/p>\n<p><strong>Group 1 Automotive (GPI)<\/strong> \u2014 Morgan Stanley maintains its Underweight rating and raises its price target to $250.00 from $232.00.<\/p>\n<p><strong>Hemab Therapeutics (COAG)<\/strong> \u2014 Lifesci Capital initiates coverage with a Outperform rating with a price target of $65.00.<\/p>\n<p><strong>Hilton Worldwide (HLT)<\/strong> \u2014 Morgan Stanley reiterates its Overweight rating with a price target of $26.00 from $32.00.<\/p>\n<p><strong>Home BancShares (HOMB)<\/strong> \u2014 Cantor Fitzgerald maintains its Neutral rating and raises its price target to $32.00 from $31.00.<\/p>\n<p><strong>Home Depot (HD)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintains its Buy rating and raises its price target to $65.00 from $78.00.<\/p>\n<p><strong>Humana (HUM)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $587.00 from $582.00.<\/p>\n<p><strong>Humana (HUM)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and raises its price target to $495.00 from $460.00.<\/p>\n<p><strong>Humana (HUM)<\/strong> \u2014 Guggenheim maintains its Buy rating and raises its price target to $521.00 from $471.00.<\/p>\n<p><strong>Humana (HUM)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and raises its price target to $526.00 from $463.00.<\/p>\n<p><strong>Huntsman (HUN)<\/strong> \u2014 KeyCorp maintains its Overweight rating and raises its price target to $13.00 from $12.00.<\/p>\n<p><strong>Hut 8 (HUT)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $22.00.<\/p>\n<p><strong>Iambic Therapeutics (IAM)<\/strong> \u2014 BofA Securities initiates coverage with a Buy rating with a price target of $30.<\/p>\n<p><strong>Iambic Therapeutics (IAM)<\/strong> \u2014 Citigroup initiates coverage with a Buy rating with a price target of $22.<\/p>\n<p><strong>Iambic Therapeutics (IAM)<\/strong> \u2014 JP Morgan initiates coverage with a Overweight rating with a price target of $22.<\/p>\n<p><strong>ICF International (ICFI)<\/strong> \u2014 Truist Financial maintains its Hold rating and raises its price target to $90.00 from $80.00.<\/p>\n<p><strong>Ichor (ICHR)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $60.00 from $70.00.<\/p>\n<p><strong>Ichor (ICHR)<\/strong> \u2014 DA Davidson initiates coverage with a Buy rating with a price target of $37.00 from $85.00.<\/p>\n<p><strong>IDEAYA Biosciences (IDYA)<\/strong> \u2014 Mizuho sets a price target of $39.00.<\/p>\n<p><strong>Innovative Industrial Properties (IIPR)<\/strong> \u2014 Alliance Global Partners upgrades the stock from Neutral to Buy with a price target of $64.00.<\/p>\n<p><strong>Inspired Entertainment (INSE)<\/strong> \u2014 Truist Financial maintains its Buy rating and lowers its price target to $6.00 from $8.00.<\/p>\n<p><strong>Installed Building Products (IBP)<\/strong> \u2014 DA Davidson maintains its Neutral rating and lowers its price target to $244.00 from $250.00.<\/p>\n<p><strong>Installed Building Products (IBP)<\/strong> \u2014 Stifel Nicolaus downgrades the stock from Buy to Hold with a price target of $225.00 from $220.00.<\/p>\n<p><strong>Insulet (PODD)<\/strong> \u2014 Truist Financial reiterates its Hold rating with a price target of $160.00 from $153.00.<\/p>\n<p><strong>Intuit (INTU)<\/strong> \u2014 TD Cowen maintains its Hold rating and raises its price target to $350.00 from $346.00.<\/p>\n<p><strong>IPG Photonics (IPGP)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $135.00 from $137.00.<\/p>\n<p><strong>IREN (IREN)<\/strong> \u2014 Compass Point reiterates its Buy rating with a price target of $55.00.<\/p>\n<p><strong>IREN (IREN)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintains its Overweight rating and lowers its price target to $55.00 from $65.00.<\/p>\n<p><strong>IREN (IREN)<\/strong> \u2014 UBS Group reiterates its Overweight rating with a price target of $21.42.<\/p>\n<p><strong>iRhythm Technologies (IRTC)<\/strong> \u2014 Truist Financial maintains its Buy rating and lowers its price target to $140.00 from $168.00.<\/p>\n<p><strong>ITT (ITT)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and raises its price target to $259.00 from $256.00.<\/p>\n<p><strong>Jazz Pharmaceuticals (JAZZ)<\/strong> \u2014 Sanford C. Bernstein reiterates its Market Perform rating with a price target of $220.00.<\/p>\n<p><strong>Joint (JYNT)<\/strong> \u2014 B. Riley Financial maintains its Neutral rating and lowers its price target to $8.00 from $9.00.<\/p>\n<p><strong>Kailera Therapeutics (KLRA)<\/strong> \u2014 Canaccord Genuity Group initiates coverage with a Buy rating with a price target of $44.00.<\/p>\n<p><strong>Karman (KRMN)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $80.00 from $79.00.<\/p>\n<p><strong>Kayne Anderson BDC (KBDC)<\/strong> \u2014 Keefe, Bruyette &amp; Woods maintains its Outperform rating and lowers its price target to $14.50 from $15.00.<\/p>\n<p><strong>Kayne Anderson BDC (KBDC)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Equal Weight rating and lowers its price target to $13.00 from $14.00.<\/p>\n<p><strong>Kimberly-Clark (KMB)<\/strong> \u2014 Barclays maintains its Equal Weight rating and raises its price target to $112.00 from $106.00.<\/p>\n<p><strong>Kimberly-Clark (KMB)<\/strong> \u2014 BNP Paribas Exane maintains its Neutral rating and raises its price target to $112.00 from $110.00.<\/p>\n<p><strong>Kinetik (KNTK)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Overweight rating and raises its price target to $56.00 from $54.00.<\/p>\n<p><strong>Koppers (KOP)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $54.00 from $62.00.<\/p>\n<p><strong>Kratos Defense &amp; Security Solutions (KTOS)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and lowers its price target to $120.00 from $135.00.<\/p>\n<p><strong>Kratos Defense &amp; Security Solutions (KTOS)<\/strong> \u2014 Guggenheim maintains its Buy rating and lowers its price target to $67.00 from $74.00.<\/p>\n<p><strong>Kratos Defense &amp; Security Solutions (KTOS)<\/strong> \u2014 Jefferies Financial Group reiterates its Buy rating with a price target of $50.00.<\/p>\n<p><strong>Krispy Kreme (DNUT)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $4.80 from $4.00.<\/p>\n<p><strong>Kulicke and Soffa Industries (KLIC)<\/strong> \u2014 B. Riley Financial maintains its Neutral rating and lowers its price target to $70.00 from $86.00.<\/p>\n<p><strong>Kura Sushi USA (KRUS)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $31.00 from $36.00.<\/p>\n<p><strong>L3Harris Technologies (LHX)<\/strong> \u2014 Citigroup initiates coverage with a Buy rating with a price target of $348.00.<\/p>\n<p><strong>Lam Research (LRCX)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $310.00 from $338.00.<\/p>\n<p><strong>Leidos (LDOS)<\/strong> \u2014 Jefferies Financial Group reiterates its Buy rating with a price target of $245.00.<\/p>\n<p><strong>Lemonade (LMND)<\/strong> \u2014 Keefe, Bruyette &amp; Woods maintains its Market Perform rating and lowers its price target to $45.00 from $48.00.<\/p>\n<p><strong>Lemonade (LMND)<\/strong> \u2014 Piper Sandler sets a price target of $45.00.<\/p>\n<p><strong>Lexicon Pharmaceuticals (LXRX)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $3.40 from $3.10.<\/p>\n<p><strong>Limbach (LMB)<\/strong> \u2014 Stifel Nicolaus sets a price target of $81.00.<\/p>\n<p><strong>LivaNova (LIVN)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $120.00 from $105.00.<\/p>\n<p><strong>Loar (LOAR)<\/strong> \u2014 Jefferies Financial Group reiterates its Buy rating with a price target of $90.00.<\/p>\n<p><strong>Lowe&#8217;s Companies (LOW)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintains its Overweight rating and raises its price target to $275.00 from $252.00.<\/p>\n<p><strong>Lyft (LYFT)<\/strong> \u2014 Canaccord Genuity Group maintains its Hold rating and raises its price target to $17.00 from $16.00.<\/p>\n<p><strong>Lyft (LYFT)<\/strong> \u2014 Fox Advisors downgrades the stock from Overweight to Equal Weight with a price target of $16.89.<\/p>\n<p><strong>Lyft (LYFT)<\/strong> \u2014 Susquehanna reiterates its Neutral rating.<\/p>\n<p><strong>Madison Air Solutions (MAIR)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and raises its price target to $36.00 from $35.00.<\/p>\n<p><strong>Magna International (MGA)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $69.00 from $75.00.<\/p>\n<p><strong>Magnite (MGNI)<\/strong> \u2014 BTIG Research maintains its Buy rating and raises its price target to $33.00 from $27.00.<\/p>\n<p><strong>Marvell Technology (MRVL)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $250.00 from $275.00.<\/p>\n<p><strong>MasTec (MTZ)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and lowers its price target to $269.00 from $313.00.<\/p>\n<p><strong>Mayville Engineering (MEC)<\/strong> \u2014 DA Davidson maintains its Buy rating and lowers its price target to $19.00 from $36.00.<\/p>\n<p><strong>MercadoLibre (MELI)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintains its Neutral rating and lowers its price target to $1,850.00 from $2,150.00.<\/p>\n<p><strong>Mercury General (MCY)<\/strong> \u2014 Raymond James Financial reiterates its Strong-Buy rating with a price target of $100.00.<\/p>\n<p><strong>MetLife (MET)<\/strong> \u2014 Mizuho sets a price target of $112.00.<\/p>\n<p><strong>MetLife (MET)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and raises its price target to $115.00 from $110.00.<\/p>\n<p><strong>Mettler-Toledo International (MTD)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $1,900.00 from $1,700.00.<\/p>\n<p><strong>Mettler-Toledo International (MTD)<\/strong> \u2014 Robert W. Baird maintains its Neutral rating and raises its price target to $1,815.00 from $1,608.00.<\/p>\n<p><strong>Mettler-Toledo International (MTD)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and raises its price target to $1,900.00 from $1,600.00.<\/p>\n<p><strong>Microchip Technology (MCHP)<\/strong> \u2014 Barclays maintains its Equal Weight rating and lowers its price target to $90.00 from $105.00.<\/p>\n<p><strong>Microchip Technology (MCHP)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and lowers its price target to $72.00 from $103.00.<\/p>\n<p><strong>Mid-America Apartment Communities (MAA)<\/strong> \u2014 Cantor Fitzgerald maintains its Neutral rating and lowers its price target to $127.00 from $140.00.<\/p>\n<p><strong>Moderna (MRNA)<\/strong> \u2014 Piper Sandler reiterates its Overweight rating with a price target of $305.00 from $230.00.<\/p>\n<p><strong>Moderna (MRNA)<\/strong> \u2014 The Goldman Sachs Group maintains its Neutral rating and raises its price target to $195.00 from $137.00.<\/p>\n<p><strong>Moelis &amp; Company (MC)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $73.00 from $77.00.<\/p>\n<p><strong>Molson Coors Beverage (TAP)<\/strong> \u2014 Barclays maintains its Underweight rating and raises its price target to $40.00 from $36.00.<\/p>\n<p><strong>Molson Coors Beverage (TAP)<\/strong> \u2014 JPMorgan Chase &amp; Co. downgrades the stock from Neutral to Underweight with a price target of $37.00 from $41.00.<\/p>\n<p><strong>Molson Coors Beverage (TAP)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and lowers its price target to $42.00 from $46.00.<\/p>\n<p><strong>Monday.com (MNDY)<\/strong> \u2014 Canaccord Genuity downgrades the stock from Buy to Hold with a price target of $90.<\/p>\n<p><strong>Monster Beverage (MNST)<\/strong> \u2014 BMO Capital Markets reiterates its Market Perform rating with a price target of $47.00.<\/p>\n<p><strong>Monster Beverage (MNST)<\/strong> \u2014 Sanford C. Bernstein maintains its Market Perform rating and raises its price target to $51.00 from $50.00.<\/p>\n<p><strong>Morgan Stanley Direct Lending Fund (MSDL)<\/strong> \u2014 Keefe, Bruyette &amp; Woods maintains its Market Perform rating and lowers its price target to $15.00 from $16.00.<\/p>\n<p><strong>Mosaic (MOS)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and lowers its price target to $23.00 from $25.00.<\/p>\n<p><strong>MP Materials (MP)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $54.00 from $65.00.<\/p>\n<p><strong>MP Materials (MP)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and lowers its price target to $70.00 from $82.00.<\/p>\n<p><strong>MSA Safety Incorporporated (MSA)<\/strong> \u2014 DA Davidson maintains its Buy rating and lowers its price target to $216.00 from $223.00.<\/p>\n<p><strong>MSA Safety Incorporporated (MSA)<\/strong> \u2014 Stifel Nicolaus sets a price target of $202.00.<\/p>\n<p><strong>Nabors Industries (NBR)<\/strong> \u2014 Barclays maintains its Equal Weight rating and lowers its price target to $85.00 from $93.00.<\/p>\n<p><strong>Natera (NTRA)<\/strong> \u2014 Robert W. Baird maintains its Outperform rating and lowers its price target to $403.00 from $458.00.<\/p>\n<p><strong>Neighborhood Intelligence (NXH)<\/strong> \u2014 Maxim Group downgrades the stock from Buy to Hold.<\/p>\n<p><strong>Nelnet (NNI)<\/strong> \u2014 TD Cowen maintains its Hold rating and lowers its price target to $125.00 from $135.00.<\/p>\n<p><strong>Netskope (NTSK)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and raises its price target to $23.00 from $20.00.<\/p>\n<p><strong>NexPoint Real Estate Finance (NREF)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and lowers its price target to $15.00 from $17.50.<\/p>\n<p><strong>Nexstar Media Group (NXST)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $225.00 from $215.00.<\/p>\n<p><strong>Nextpower (NXT)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and raises its price target to $115.00 from $110.00.<\/p>\n<p><strong>Nkarta (NKTX)<\/strong> \u2014 Needham &amp; Company LLC reiterates its Buy rating.<\/p>\n<p><strong>Norwood Financial (NWFL)<\/strong> \u2014 Stephens maintains its Equal Weight rating and raises its price target to $37.00 from $35.00.<\/p>\n<p><strong>Nutex Health (NUTX)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and raises its price target to $357.00 from $325.00.<\/p>\n<p><strong>NVIDIA (NVDA)<\/strong> \u2014 Royal Bank Of Canada reiterates its Outperform rating with a price target of $330.00.<\/p>\n<p><strong>NVIDIA (NVDA)<\/strong> \u2014 Sanford C. Bernstein reiterates its Outperform rating.<\/p>\n<p><strong>NVIDIA (NVDA)<\/strong> \u2014 The Goldman Sachs Group reiterates its Buy rating with a price target of $300.00.<\/p>\n<p><strong>OFG Bancorp (OFG)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Equal Weight rating and lowers its price target to $53.00 from $55.00.<\/p>\n<p><strong>Oklo (OKLO)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and lowers its price target to $66.00 from $100.00.<\/p>\n<p><strong>Oklo (OKLO)<\/strong> \u2014 HC Wainwright reiterates its Buy rating with a price target of $90.00.<\/p>\n<p><strong>Oklo (OKLO)<\/strong> \u2014 Wedbush reiterates its Outperform rating with a price target of $36.00.<\/p>\n<p><strong>Old National Bancorp (ONB)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Overweight rating and lowers its price target to $29.00 from $30.00.<\/p>\n<p><strong>Ollie&#8217;s Bargain Outlet (OLLI)<\/strong> \u2014 KeyCorp maintains its Overweight rating and raises its price target to $120.00 from $98.00.<\/p>\n<p><strong>Ollie&#8217;s Bargain Outlet (OLLI)<\/strong> \u2014 Raymond James Financial sets a price target of $120.00.<\/p>\n<p><strong>Omega Healthcare Investors (OHI)<\/strong> \u2014 Raymond James Financial reiterates its Outperform rating with a price target of $54.00.<\/p>\n<p><strong>ON (ONON)<\/strong> \u2014 Piper Sandler reiterates its Overweight rating.<\/p>\n<p><strong>Onto Innovation (ONTO)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $285.00 from $340.00.<\/p>\n<p><strong>Ormat Technologies (ORA)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and lowers its price target to $120.00 from $142.00.<\/p>\n<p><strong>Oshkosh (OSK)<\/strong> \u2014 Raymond James Financial reiterates its Outperform rating with a price target of $165.00.<\/p>\n<p><strong>Owens Corning (OC)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $156.00 from $177.00.<\/p>\n<p><strong>PagerDuty (PD)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $14.00 from $12.00.<\/p>\n<p><strong>Palvella Therapeutics (PVLA)<\/strong> \u2014 Canaccord Genuity Group maintains its Buy rating and raises its price target to $243.00 from $232.00.<\/p>\n<p><strong>Pan American Silver (PAAS)<\/strong> \u2014 TD Cowen downgrades the stock from Buy to Hold.<\/p>\n<p><strong>Parabilis Medicines (PBLS)<\/strong> \u2014 Canaccord Genuity Group initiates coverage with a Buy rating with a price target of $39.00.<\/p>\n<p><strong>Parker-Hannifin (PH)<\/strong> \u2014 Sanford C. Bernstein reiterates its Outperform rating.<\/p>\n<p><strong>Patrick Industries (PATK)<\/strong> \u2014 Wells Fargo &amp; Company initiates coverage with a Overweight rating with a price target of $95.00.<\/p>\n<p><strong>Paylocity (PCTY)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $214.00 from $208.00.<\/p>\n<p><strong>PayPay (PAYP)<\/strong> \u2014 Cantor Fitzgerald maintains its Overweight rating and lowers its price target to $21.00 from $25.00.<\/p>\n<p><strong>PDD (PDD)<\/strong> \u2014 Morgan Stanley downgrades the stock from Overweight to Equal Weight with a price target of $90.00 from $129.00.<\/p>\n<p><strong>PENN Entertainment (PENN)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $19.00 from $17.00.<\/p>\n<p><strong>Penske Automotive Group (PAG)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $212.00 from $210.00.<\/p>\n<p><strong>Planet Fitness (PLNT)<\/strong> \u2014 TD Cowen maintains its Hold rating and raises its price target to $61.00 from $54.00.<\/p>\n<p><strong>Popular (BPOP)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Overweight rating and lowers its price target to $190.00 from $195.00.<\/p>\n<p><strong>PPL (PPL)<\/strong> \u2014 BMO Capital Markets reiterates its Outperform rating.<\/p>\n<p><strong>PPL (PPL)<\/strong> \u2014 Mizuho sets a price target of $38.00.<\/p>\n<p><strong>PPL (PPL)<\/strong> \u2014 Piper Sandler sets a price target of $40.00.<\/p>\n<p><strong>Praxis Precision Medicines (PRAX)<\/strong> \u2014 BTIG Research reiterates its Buy rating with a price target of $826.00.<\/p>\n<p><strong>Primo Brands (PRMB)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $29.00 from $26.00.<\/p>\n<p><strong>Primo Brands (PRMB)<\/strong> \u2014 Morgan Stanley maintains its Overweight rating and lowers its price target to $28.00 from $29.00.<\/p>\n<p><strong>Primoris Services (PRIM)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and lowers its price target to $80.00 from $90.00.<\/p>\n<p><strong>ProFrac (ACDC)<\/strong> \u2014 Morgan Stanley maintains its Underweight rating and lowers its price target to $4.00 from $4.50.<\/p>\n<p><strong>ProFrac (ACDC)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and lowers its price target to $5.00 from $6.00.<\/p>\n<p><strong>Protagonist Therapeutics (PTGX)<\/strong> \u2014 Wedbush reiterates its Outperform rating.<\/p>\n<p><strong>Qualcomm (QCOM)<\/strong> \u2014 Freedom Broker downgrades the stock from Buy to Hold with a price target of $185.00 from $200.00.<\/p>\n<p><strong>Quanta Services (PWR)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and lowers its price target to $701.00 from $714.00.<\/p>\n<p><strong>Quantinuum (QNT)<\/strong> \u2014 Bank of America maintains its Buy rating and lowers its price target to $50.00 from $85.00.<\/p>\n<p><strong>Rayonier (RYN)<\/strong> \u2014 Citigroup maintains its Neutral rating and raises its price target to $23.00 from $19.00.<\/p>\n<p><strong>Ready Capital (RC)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and lowers its price target to $1.00 from $1.25.<\/p>\n<p><strong>Reinsurance Group of America (RGA)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and raises its price target to $300.00 from $274.00.<\/p>\n<p><strong>Remitly Global (RELY)<\/strong> \u2014 Cantor Fitzgerald reiterates its Overweight rating with a price target of $30.00.<\/p>\n<p><strong>Rigel Pharmaceuticals (RIGL)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $86.00 from $83.00.<\/p>\n<p><strong>Rigetti Computing (RGTI)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $23.00 from $25.00.<\/p>\n<p><strong>Rivian Automotive (RIVN)<\/strong> \u2014 Stifel Nicolaus reiterates its Buy rating with a price target of $22.00.<\/p>\n<p><strong>Rogers (ROG)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $180.00 from $195.00.<\/p>\n<p><strong>Rollins (ROL)<\/strong> \u2014 Citigroup upgrades the stock from Neutral to Buy with a price target of $49.00 from $32.00.<\/p>\n<p><strong>Rollins (ROL)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Underweight rating and raises its price target to $30.00 from $26.00.<\/p>\n<p><strong>Sanofi (SNY)<\/strong> \u2014 BNP Paribas Exane upgrades the stock from Neutral to Outperform with a price target of $57.00.<\/p>\n<p><strong>SAP (SAP)<\/strong> \u2014 JPMorgan Chase &amp; Co. upgrades the stock from Neutral to Overweight.<\/p>\n<p><strong>Seadrill (SDRL)<\/strong> \u2014 Barclays maintains its Overweight rating and raises its price target to $61.00 from $59.00.<\/p>\n<p><strong>Semtech (SMTC)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $190.00 from $210.00.<\/p>\n<p><strong>Seneca Foods (SENEA)<\/strong> \u2014 Freedom Broker upgrades the stock from Hold to Buy with a price target of $202.00.<\/p>\n<p><strong>SharkNinja (SN)<\/strong> \u2014 Guggenheim maintains its Buy rating and raises its price target to $250.00 from $210.00.<\/p>\n<p><strong>Shoals Technologies Group (SHLS)<\/strong> \u2014 Royal Bank Of Canada maintains its Outperform rating and raises its price target to $11.00 from $10.00.<\/p>\n<p><strong>Silicon Motion Technology (SIMO)<\/strong> \u2014 B. Riley Financial maintains its Buy rating and lowers its price target to $290.00 from $310.00.<\/p>\n<p><strong>SiriusPoint (SPNT)<\/strong> \u2014 Oppenheimer reiterates its Overweight rating with a price target of $3.40.<\/p>\n<p><strong>Six Flags Entertainment (FUN)<\/strong> \u2014 Citigroup maintains its Neutral rating and lowers its price target to $10.00 from $13.00.<\/p>\n<p><strong>Skyward Specialty Insurance Group (SKWD)<\/strong> \u2014 Jefferies Financial Group reiterates its Hold rating with a price target of $64.00.<\/p>\n<p><strong>Smartstop Self Storage REIT (SMA)<\/strong> \u2014 Freedom Broker downgrades the stock from Buy to Hold with a price target of $40.00 from $38.00.<\/p>\n<p><strong>Smartstop Self Storage REIT (SMA)<\/strong> \u2014 KeyCorp maintains its Overweight rating and raises its price target to $42.00 from $40.00.<\/p>\n<p><strong>Sohu.com (SOHU)<\/strong> \u2014 Jefferies Financial Group reiterates its Buy rating with a price target of $18.70.<\/p>\n<p><strong>Solaris Energy Infrastructure (SEI)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $104.00 from $100.00.<\/p>\n<p><strong>Solaris Energy Infrastructure (SEI)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and raises its price target to $85.00 from $82.00.<\/p>\n<p><strong>Solid Biosciences (SLDB)<\/strong> \u2014 William Blair initiates coverage with a Outperform rating with a price target of $7.09.<\/p>\n<p><strong>Southern (SO)<\/strong> \u2014 Capital One Financial sets a price target of $99.00.<\/p>\n<p><strong>StandardAero (SARO)<\/strong> \u2014 BTIG Research reiterates its Buy rating with a price target of $35.00.<\/p>\n<p><strong>StandardAero (SARO)<\/strong> \u2014 Jefferies Financial Group reiterates its Hold rating with a price target of $28.00.<\/p>\n<p><strong>Starbucks (SBUX)<\/strong> \u2014 Stifel Nicolaus initiates coverage with a Buy rating with a price target of $115.00.<\/p>\n<p><strong>Strategy (MSTR)<\/strong> \u2014 Cantor Fitzgerald reiterates its Overweight rating with a price target of $208.00.<\/p>\n<p><strong>Strive (ASST)<\/strong> \u2014 B. Riley Financial reiterates its Buy rating with a price target of $27.00 from $33.00.<\/p>\n<p><strong>Stryker (SYK)<\/strong> \u2014 Piper Sandler maintains its Overweight rating and raises its price target to $350.00 from $325.00.<\/p>\n<p><strong>Supernus Pharma (SUPN)<\/strong> \u2014 BofA Securities initiates coverage with a Buy rating with a price target of $47.<\/p>\n<p><strong>Supernus Pharmaceuticals (SUPN)<\/strong> \u2014 Bank of America initiates coverage with a Buy rating with a price target of $47.00.<\/p>\n<p><strong>Sylvamo (SLVM)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $37.00 from $35.00.<\/p>\n<p><strong>Sylvamo (SLVM)<\/strong> \u2014 Truist Financial reiterates its Buy rating with a price target of $47.00 from $40.00.<\/p>\n<p><strong>Targa Resources (TRGP)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Overweight rating and raises its price target to $330.00 from $324.00.<\/p>\n<p><strong>Target (TGT)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintains its Neutral rating and raises its price target to $163.00 from $157.00.<\/p>\n<p><strong>TechTarget (TTGT)<\/strong> \u2014 Needham &amp; Company LLC reiterates its Buy rating with a price target of $8.00.<\/p>\n<p><strong>Teladoc Health (TDOC)<\/strong> \u2014 TD Cowen maintains its Hold rating and raises its price target to $8.00 from $6.00.<\/p>\n<p><strong>Teleflex (TFX)<\/strong> \u2014 Truist Financial maintains its Hold rating and raises its price target to $167.00 from $142.00.<\/p>\n<p><strong>Tenaris (TS)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and raises its price target to $65.00 from $62.00.<\/p>\n<p><strong>Tenaris (TS)<\/strong> \u2014 Piper Sandler maintains its Neutral rating and raises its price target to $67.00 from $60.00.<\/p>\n<p><strong>TeraWulf (WULF)<\/strong> \u2014 Needham &amp; Company LLC maintains its Buy rating and lowers its price target to $25.00 from $33.00.<\/p>\n<p><strong>TeraWulf (WULF)<\/strong> \u2014 Rosenblatt Securities maintains its Buy rating and lowers its price target to $20.00 from $30.00.<\/p>\n<p><strong>Thor Industries (THO)<\/strong> \u2014 Wells Fargo &amp; Company initiates coverage with a Equal Weight rating with a price target of $80.00.<\/p>\n<p><strong>Titan America (TTAM)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $15.00 from $18.00.<\/p>\n<p><strong>Transocean (RIG)<\/strong> \u2014 Morgan Stanley maintains its Equal Weight rating and lowers its price target to $6.50 from $7.00.<\/p>\n<p><strong>TransUnion (TRU)<\/strong> \u2014 Rothschild &amp; Co Redburn downgrades the stock from Buy to Neutral with a price target of $91.00 from $89.00.<\/p>\n<p><strong>Treace Medical Concepts (TMCI)<\/strong> \u2014 Stifel Nicolaus upgrades the stock from Hold to Buy with a price target of $6.50 from $4.50.<\/p>\n<p><strong>Treace Medical Concepts (TMCI)<\/strong> \u2014 UBS Group upgrades the stock from Neutral to Buy.<\/p>\n<p><strong>Trimble (TRMB)<\/strong> \u2014 Barclays maintains its Overweight rating and lowers its price target to $78.00 from $80.00.<\/p>\n<p><strong>TripAdvisor (TRIP)<\/strong> \u2014 Jefferies Financial Group upgrades the stock from Underperform to Hold with a price target of $7.00 from $8.00.<\/p>\n<p><strong>Tronox (TROX)<\/strong> \u2014 JPMorgan Chase &amp; Co. upgrades the stock from Underweight to Neutral.<\/p>\n<p><strong>Trupanion (TRUP)<\/strong> \u2014 Cantor Fitzgerald maintains its Neutral rating and raises its price target to $33.00 from $30.00.<\/p>\n<p><strong>Trupanion (TRUP)<\/strong> \u2014 Stifel Nicolaus maintains its Hold rating and raises its price target to $34.00 from $29.00.<\/p>\n<p><strong>Uber Technologies (UBER)<\/strong> \u2014 Citigroup initiates coverage with a Buy rating with a price target of $105.00.<\/p>\n<p><strong>Ubiquiti (UI)<\/strong> \u2014 Barclays maintains its Underweight rating and raises its price target to $537.00 from $489.00.<\/p>\n<p><strong>Unisys (UIS)<\/strong> \u2014 Jefferies Financial Group reiterates its Hold rating with a price target of $2.75.<\/p>\n<p><strong>United Dominion Realty Trust (UDR)<\/strong> \u2014 Cantor Fitzgerald maintains its Neutral rating and lowers its price target to $39.00 from $41.00.<\/p>\n<p><strong>United Therapeutics (UTHR)<\/strong> \u2014 HC Wainwright initiates coverage with a Buy rating with a price target of $660.00.<\/p>\n<p><strong>Univest Corporation of Pennsylvania (UVSP)<\/strong> \u2014 Piper Sandler reiterates its Neutral rating with a price target of $45.00 from $46.00.<\/p>\n<p><strong>Unum Group (UNM)<\/strong> \u2014 JPMorgan Chase &amp; Co. upgrades the stock from Neutral to Overweight with a price target of $90.00 from $98.00.<\/p>\n<p><strong>Valley National Bancorp (VLY)<\/strong> \u2014 Keefe, Bruyette &amp; Woods downgrades the stock from Outperform to Market Perform with a price target of $17.00.<\/p>\n<p><strong>Veeva Systems (VEEV)<\/strong> \u2014 BTIG Research maintains its Buy rating and raises its price target to $360.00 from $340.00.<\/p>\n<p><strong>Veeva Systems (VEEV)<\/strong> \u2014 Canaccord Genuity Group maintains its Hold rating and raises its price target to $315.00 from $260.00.<\/p>\n<p><strong>Veeva Systems (VEEV)<\/strong> \u2014 Truist Financial maintains its Buy rating and raises its price target to $360.00 from $305.00.<\/p>\n<p><strong>Viasat (VSAT)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintains its Overweight rating and lowers its price target to $120.00 from $130.00.<\/p>\n<p><strong>Viemed Healthcare (VMD)<\/strong> \u2014 Freedom Broker maintains its Neutral rating and lowers its price target to $68.00 from $70.00.<\/p>\n<p><strong>Viking (VIK)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Overweight rating and lowers its price target to $118.00 from $128.00.<\/p>\n<p><strong>Vir Biotechnology (VIR)<\/strong> \u2014 HC Wainwright reiterates its Buy rating with a price target of $22.00.<\/p>\n<p><strong>Vistra (VST)<\/strong> \u2014 Scotiabank maintains its Sector Outperform rating and lowers its price target to $169.00 from $189.00.<\/p>\n<p><strong>Vivid Seats (SEAT)<\/strong> \u2014 Craig Hallum downgrades the stock from Buy to Hold with a price target of $2.<\/p>\n<p><strong>Vontier (VNT)<\/strong> \u2014 Robert W. Baird maintains its Neutral rating and raises its price target to $46.00 from $39.00.<\/p>\n<p><strong>Vulcan Materials (VMC)<\/strong> \u2014 Stifel Nicolaus maintains its Buy rating and raises its price target to $342.00 from $320.00.<\/p>\n<p><strong>Walmart (WMT)<\/strong> \u2014 JPMorgan Chase &amp; Co. maintains its Overweight rating and raises its price target to $145.00 from $125.00.<\/p>\n<p><strong>Watts Water Technologies (WTS)<\/strong> \u2014 Stifel Nicolaus sets a price target of $430.00.<\/p>\n<p><strong>WAVE Life Sciences (WVE)<\/strong> \u2014 B. Riley Financial reiterates its Buy rating with a price target of $18.00.<\/p>\n<p><strong>Wayfair (W)<\/strong> \u2014 Citigroup maintains its Buy rating and raises its price target to $145.00 from $133.00.<\/p>\n<p><strong>Wendy&#8217;s (WEN)<\/strong> \u2014 Royal Bank Of Canada maintains its Sector Perform rating and raises its price target to $8.00 from $7.00.<\/p>\n<p><strong>Western Alliance Bancorporation (WAL)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Equal Weight rating and lowers its price target to $82.00 from $84.00.<\/p>\n<p><strong>Western Union (WU)<\/strong> \u2014 Cantor Fitzgerald reiterates its Underweight rating with a price target of $6.00.<\/p>\n<p><strong>Westlake (WLK)<\/strong> \u2014 Truist Financial maintains its Buy rating and lowers its price target to $81.00 from $90.00.<\/p>\n<p><strong>Winnebago Industries (WGO)<\/strong> \u2014 Wells Fargo &amp; Company initiates coverage with a Underweight rating with a price target of $27.00.<\/p>\n<p><strong>Wintrust Financial (WTFC)<\/strong> \u2014 Wells Fargo &amp; Company maintains its Equal Weight rating and raises its price target to $165.00 from $160.00.<\/p>\n<p><strong>Wynn Resorts (WYNN)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $100.00 from $103.00.<\/p>\n<p><strong>Zillow Group (ZG)<\/strong> \u2014 Citigroup maintains its Buy rating and lowers its price target to $42.00 from $52.00.<\/p>\n<p><strong>Zillow Group (ZG)<\/strong> \u2014 KeyCorp downgrades the stock from Overweight to Sector Weight.<\/p>\n<p><strong>Zimmer Biomet (ZBH)<\/strong> \u2014 Barclays maintains its Equal Weight rating and raises its price target to $115.00 from $10<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Analyst Ratings (USA) American sentiment on November 9th remains cautiously optimistic but increasingly selective, with positive recommendations concentrated in artificial intelligence, semiconductors, industrials, and&hellip;<\/p>\n","protected":false},"author":3,"featured_media":76841,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76965","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>American Analyst Updates: Nov 9th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"American Analyst Updates: Nov 9th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) American sentiment on November 9th remains cautiously optimistic but increasingly selective, with positive recommendations concentrated in artificial intelligence, semiconductors, industrials, and&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-09T21:19:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/11\/Wall-Street-Analyst-Updates-Banner.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"35 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"American Analyst Updates: Nov 9th, 2026\",\"datePublished\":\"2026-11-09T21:19:30+00:00\",\"dateModified\":\"2026-11-09T21:19:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/\"},\"wordCount\":7091,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/\",\"name\":\"American Analyst Updates: Nov 9th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-11-09T21:19:30+00:00\",\"dateModified\":\"2026-11-09T21:19:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"American Analyst Updates: Nov 9th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"American Analyst Updates: Nov 9th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/","og_locale":"en_US","og_type":"article","og_title":"American Analyst Updates: Nov 9th, 2026","og_description":"Analyst Ratings (USA) American sentiment on November 9th remains cautiously optimistic but increasingly selective, with positive recommendations concentrated in artificial intelligence, semiconductors, industrials, and&hellip;","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-11-09T21:19:30+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/11\/Wall-Street-Analyst-Updates-Banner.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"35 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"American Analyst Updates: Nov 9th, 2026","datePublished":"2026-11-09T21:19:30+00:00","dateModified":"2026-11-09T21:19:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/"},"wordCount":7091,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/","name":"American Analyst Updates: Nov 9th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-11-09T21:19:30+00:00","dateModified":"2026-11-09T21:19:30+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-9th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"American Analyst Updates: Nov 9th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=76965"}],"version-history":[{"count":1,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76965\/revisions"}],"predecessor-version":[{"id":76968,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76965\/revisions\/76968"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/76841"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=76965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=76965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=76965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}